Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer

Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer

Fibroblast growth factor receptor (FGFR) inhibitors (FGFRis) are a potential therapeutic option for squamous non-small cell lung cancer (Sq-NSCLC). Because appropriate patient selection is needed for targeted therapy, molecular profiling is key to discovering candidate biomarker(s). Multiple FGFR ab...

Full description

Bibliographic Details
Main Authors: Joanna Moes-Sosnowska, Joanna Chorostowska-Wynimko
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
fibroblast growth factor receptor
FGFR inhibitors
squamous non-small cell lung cancer (Sq-NSCLC)
molecular biomarkers
targeted therapy
FGFR1
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.780650/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.780650/full

Similar Items